KVUE
Q4 2026 EPS Estimate
$0.28
Nov 2, 2026
Revenue Estimate
$3.86B
FY2026E EPS$1.20
FY2027E EPS$1.26

Analyst Sentiment

Wall St. Consensus
Hold
12 analysts·Moderate coverage
58
Score
4 Buy (33%)8 Hold (67%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
433%
Hold
867%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$18.00
-6.8%
Consensus
$19.00
-1.6%
Bull
$20.00
+3.6%
12-Month Target Range12 analysts
$18.00$19.00$20.00
Current $19.30Consensus
Current Price
$19.30
Above Consensus
$0.30

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+2.43%
EPS+5.32%
FY2028
Rev+3.34%
EPS+5.61%
FY2029
Rev+2.70%
EPS+5.08%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$15.64B$16.02B$16.55B$17.00B$17.30B
Low$15.52B$15.88B$16.47B$16.86B$17.16B
High$15.74B$16.24B$16.67B$17.11B$17.41B
EBITDA Avg$3.20B$3.27B$3.38B$3.47B$3.54B
Low$3.17B$3.24B$3.37B$3.44B$3.51B
High$3.22B$3.32B$3.41B$3.50B$3.56B
EBIT Avg$2.54B$2.60B$2.69B$2.76B$2.81B
Low$2.52B$2.58B$2.68B$2.74B$2.79B
High$2.56B$2.64B$2.71B$2.78B$2.83B
Net Income Avg$2.29B$2.42B$2.55B$2.69B$2.71B
Low$2.03B$2.17B$2.41B$2.66B$2.68B
High$2.50B$2.66B$2.80B$2.72B$2.73B
EPS Avg$1.20$1.26$1.33$1.40$1.41
Low$1.05$1.13$1.25$1.38$1.39
High$1.30$1.38$1.45$1.41$1.42
Analysts (Rev / EPS)10 / 810 / 88 / 34 / 14 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$3.88B$3.89B$4.01B$4.07B$3.98B$3.97B$4.16B$4.21B
Low$3.85B$3.84B$3.98B$4.05B$3.95B$3.94B$4.13B$4.18B
High$3.93B$4.01B$4.06B$4.13B$4.03B$4.02B$4.21B$4.26B
EBITDA Avg$793M$794M$819M$833M$812M$811M$850M$860M
Low$787M$784M$813M$827M$807M$805M$844M$854M
High$803M$820M$829M$843M$822M$821M$861M$871M
EBIT Avg$630M$632M$651M$662M$646M$645M$676M$684M
Low$626M$623M$646M$657M$641M$640M$671M$679M
High$638M$652M$659M$670M$654M$653M$685M$693M
Net Income Avg$581M$516M$640M$636M$607M$542M$674M$676M
Low$504M$481M$634M$630M$602M$537M$667M$670M
High$639M$563M$651M$646M$617M$550M$684M$687M
EPS Avg$0.30$0.27$0.33$0.33$0.32$0.28$0.35$0.35
Low$0.26$0.25$0.33$0.33$0.31$0.28$0.35$0.35
High$0.33$0.29$0.34$0.34$0.32$0.29$0.36$0.36
Analysts (Rev / EPS)6 / 69 / 95 / 48 / 74 / 35 / 45 / 63 / 4

Earnings Surprises

Recent Analyst Actions

Jul 21, 2026Barclays
Kenvue price target raised to $19 from $18 at Barclays
Target:$19.00
-0.1%from $19.02
Jul 16, 2026UBS
Kenvue price target raised to $20 from $18 at UBS
Target:$20.00
+5.8%from $18.91
Apr 14, 2026Barclays
Kenvue price target lowered to $18 from $19 at Barclays
Target:$18.00
+3.5%from $17.39
Feb 18, 2026UBS
Kenvue price target raised to $19 from $17 at UBS
Target:$19.00
+3.2%from $18.41
Feb 18, 2026Canaccord Genuity
Kenvue price target raised to $18 from $17 at Canaccord
Target:$18.00
-2.2%from $18.41
Jan 30, 2026Jefferies
Kenvue downgraded to Hold from Buy at Jefferies
Target:$18.00
+4.7%from $17.20
Oct 29, 2025Canaccord Genuity
Kenvue downgraded to Hold from Buy at Canaccord
Target:$15.00
+3.4%from $14.51
Oct 28, 2025Evercore ISI
Evercore ISI Warns on Kenvue Inc (KVUE) Amid 3.5pct Decline: 'It's not just Tylenol'
Target:$18.00
+24.2%from $14.49
Oct 27, 2025Jefferies
Kenvue Inc (KVUE) PT Lowered to $23 at JefferiesMember Login
Target:$23.00
+53.3%from $15.00
Oct 24, 2025Deutsche Bank
Kenvue price target lowered to $18 from $20 at Deutsche Bank
Target:$18.00
+19.5%from $15.06
Oct 8, 2025UBS
Kenvue price target lowered to $17 from $23 at UBS
Target:$17.00
+4.9%from $16.20
Oct 1, 2025Barclays
Kenvue price target lowered to $17 from $20 at Barclays
Target:$17.00
+4.7%from $16.23
Sep 26, 2025Redburn Partners
Kenvue upgraded to Buy from Neutral at Rothschild & Co Redburn
Target:$22.00
+36.1%from $16.17
Mar 27, 2025Barclays
Kenvue price target raised to $23 from $21 at Barclays
Target:$23.00
-2.1%from $23.50
Mar 5, 2025Canaccord Genuity
Kenvue price target raised to $29 from $24 at Canaccord
Target:$29.00
+25.9%from $23.04
Nov 5, 2024Canaccord Genuity
Kenvue Inc (KVUE) PT Raised to $27 at Canaccord Genuity
Target:$27.00
+16.5%from $23.18
Sep 24, 2024RBC Capital
RBC Capital Downgrades Kenvue Inc (KVUE) to Sector Perform
Target:$24.00
+4.3%from $23.02
Sep 23, 2024Jefferies
Jefferies Starts Kenvue Inc (KVUE) at Buy
Target:$27.00
+17.3%from $23.02
Sep 23, 2024Piper Sandler
Kenvue price target raised to $21 from $20 at Piper Sandler
Target:$21.00
-8.8%from $23.02
May 20, 2024Goldman Sachs
Kenvue Inc (KVUE) PT Raised to $21 at Goldman Sachs
Target:$21.00
+2.6%from $20.47
Apr 10, 2024Bernstein
Bernstein SocGen Group Starts Kenvue Inc (KVUE) at Underperform
Target:$18.00
-11.1%from $20.24
Apr 9, 2024Piper Sandler
Piper Sandler Reiterates Overweight Rating on Kenvue Inc (KVUE), 'Brands moving up in preference'
Target:$20.00
-0.3%from $20.06
May 30, 2023RBC Capital
Kenvue's Growth Forecast: Exploring The Future Of Johnson & Johnson's Carve-Out
Target:$29.00
+15.6%from $25.09
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.